BUPIVACAINE HCL
Generic: BUPIVACAINE HYDROCHLORIDE
BUPIVACAINE HCL is FDA application ANDA091503, sponsored by ONESOURCE SPECIALTY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Presence of particulate matter: visible free floating and partially embedded particulate matter in t
cGMP deviations: Temperature abuse
Presence of particulate matter: visible free floating and partially embedded particulate matter in t
Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the gla
Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP
Presence of particulate matter: Confirmed customer report for the presence of particulate matter wit
Lack of Assurance of Sterility; potential for vial breakage
Lack of Assurance of Sterility